We performed qRT-PCR analysis on MB49 and B16F10 tumor tissues harvested from mice that were systemically treated with either EC5026, ICIs (anti-PD-1 or anti-CTLA4), a combination of EC5026 and ICIs, or vehicle as detailed above. This evidence concerns the gene CTLA4 and neoplasm.